1Gugnani MK,Pierson C,Vanderheide R, et al. Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma:a case of pulmonary capillary hemangiomatosis. Arthritis Rheum,2000,43:699-703.
2Abraham DJ,Vancheeswaran R, Dashwood MR, et al.Increased levels of endothelin 1 and differential endothelin type A and B receptor expression in scleroderma associated fibrotic lung disease. Am J Pathol, 1997,151:831-841.
3Greidinger EL,Gaine SP,Wise RA.Primary pulmonary hypertension is not associated with scleroderma like changes in nailfold capillaries.Chest,2001,120:796-800.
4Battle RW,Davitt MA,Cooper SM,et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest, 1996,110:1515-1519.
5Denton CP, Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol, 1997 , 36:239-243.
6Hoeper MM.Pulmonary hypertension in collagen vascular disease. Eur Respir J,2002,19:571-576.
7Klings ES,Hill NS,Ieong MH,et al. Systemic sclerosis associated pulmonary hypertension:short and long term effects of epoprostenol (prostacyolin).Arthritis Rheum, 1999,42:2638-2645.
8de la Mata J,Gomez Sanchez MA, Aranzana M,et al. Long term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum,1994,37:1528-1533.
9Humbert M,Cabane J.Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan. Rheumatology (Oxford),2003,42:191-193.
10Varga J.Pulmonary hypertension in systemic sclerosis:bete noire no more? Curr Opin Rheumatol,2002,14:666-670.
